The Valley Desk

NCT02043665 · Interventional trial

CVA21 and Pembrolizumab in NSCLC & Bladder Cancer (VLA-009 STORM/ KEYNOTE-200)

Overall registry status Completed

Phase 1

Conditions Bladder Cancer, Non-small Cell Lung Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov